A review of the management of the male breast carcinoma based on an analysis of 420 treated cases

[1]  D. Lebwohl,et al.  Tamoxifen adminstration is associated with a high rate of treatment‐limiting symptoms in male breast cancer patients , 1994 .

[2]  F. Pignatti,et al.  Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer , 1993, Cancer.

[3]  G. Ribeiro,et al.  Adjuvant tamoxifen for male breast cancer (MBC). , 1992, British Journal of Cancer.

[4]  G. Ribeiro,et al.  Use of an electron beam for post-mastectomy radiotherapy: 5-year follow-up of 500 cases. , 1991, Clinical oncology (Royal College of Radiologists (Great Britain)).

[5]  G. Secreto,et al.  Hormones in Male Breast Cancer , 1990, Tumori.

[6]  M. Pike,et al.  A case-control study of male breast cancer. , 1988, Cancer research.

[7]  M. Lippman,et al.  Adjuvant Chemotherapy in Males with Cancer of the Breast , 1987, American journal of clinical oncology.

[8]  M. Dowsett,et al.  Role of aminoglutethimide in male breast cancer. , 1986, British journal of cancer.

[9]  C. Redondo,et al.  Lobular carcinoma of the breast in a patient with klinefelter's syndrome. A case with bilateral, synchronous, histologically different breast tumors , 1986, Cancer.

[10]  G. Ribeiro.  Male breast carcinoma--a review of 301 cases from the Christie Hospital & Holt Radium Institute, Manchester. , 1985, British Journal of Cancer.

[11]  E. Montague,et al.  Treatment results in males with breast cancer , 1980, Cancer.

[12]  G. Ribeiro,et al.  Serum oestradiol-17 beta, testosterone, luteinizing hormone and follicle-stimulating hormone in males with breast cancer. , 1980, British Journal of Cancer.

[13]  D. Barnes,et al.  Two methods for measurement of oestradiol-17 beta and progesterone receptors in human breast cancer and correlation with response treatment. , 1977, European journal of cancer.

[14]  P. Rosen,et al.  Medullary carcinoma of the breast. A clinicopathologic study with 10 year follow‐up , 1977, Cancer.

[15]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[16]  D. Tormey,et al.  Male breast cancer: a review. , 1976, Cancer treatment reviews.

[17]  G. Ribeiro.  The results of diethylstilboestrol therapy for recurrent and metastatic carcinoma of the male breast. , 1976, British Journal of Cancer.

[18]  O. Scheike.  Male Breast Cancer , 1974, British Journal of Cancer.

[19]  J. Visfeldt,et al.  Male breast cancer. I. Histologic typing and grading of 187 Danish cases , 1973, Cancer.

[20]  W. W. Richardson.  Medullary Carcinoma of the Breast , 1956, British Journal of Cancer.

[21]  J. Farrow,et al.  EFFECT OF ORCHIDECTOMY ON SKELETAL METASTASES FROM CANCER OF THE MALE BREAST. , 1942, Science.

[22]  R. Hultborn,et al.  Male breast carcinoma. I. A study of the total material reported to the Swedish Cancer Registry 1958-1967 with respect to clinical and histopathologic parameters. , 1987, Acta oncologica.

[23]  S. Wells,et al.  Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease , 1984, Cancer.

[24]  G. Ribeiro.  Tamoxifen in the treatment of male breast carcinoma. , 1983, Clinical radiology.

[25]  R. W. Scarff,et al.  Histological typing of breast tumors. , 1982, Tumori.

[26]  Massimo Lopez,et al.  Cyproterone acetate in advanced male breast cancer , 1982 .

[27]  G. Kerr,et al.  Carcinoma of the male breast: report of a series of 88 cases. , 1976, Clinical radiology.